Wordt geladen...
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases
Pertuzumab, a humanized antibody drug, has improved outcomes of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, when administered in combination with trastuzumab and other chemotherapies. Cardiotoxicity due to trastuzumab is widely recognized, while data on pert...
Bewaard in:
| Gepubliceerd in: | Case Rep Oncol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983593/ https://ncbi.nlm.nih.gov/pubmed/33776683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000513002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|